Function and Regulation of Human Cytochrome P4502S1
人细胞色素P4502S1的功能和调控
基本信息
- 批准号:7476561
- 负责人:
- 金额:$ 24.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-09-28 至 2011-07-31
- 项目状态:已结题
- 来源:
- 关键词:5&apos Flanking RegionAddressAdverse effectsAflatoxin B1AntibodiesAntioxidantsAromatic HydrocarbonsAromatic Polycyclic HydrocarbonsAryl Hydrocarbon ReceptorBacteriaBacterial Artificial ChromosomesBase SequenceBenzo(a)pyreneBiologicalCYP1B1 geneCYP2S1 geneCarcinogen MetabolismCarcinogensCell LineCellsComplementCytochrome P450CytochromesDevelopmentDioxinsDiseaseElementsEnvironmentEnvironmental CarcinogensEnzymesEpidermisEpithelialEpitheliumFamily memberGenesGoalsHumanHypoxiaIndiumIntestinesInvestigationKnockout MiceLungMammalian CellMediatingMetabolic ActivationMetabolismMusNaphthaleneNaphthalenesNucleic Acid Regulatory SequencesOrganPathway interactionsPatternPharmacologic SubstancePhysiologyPlayPoisonPolycyclic HydrocarbonsPopulationProtein OverexpressionProteinsRegulationResearch PersonnelRespiratory SystemResponse ElementsRoleSkinStructure of respiratory epitheliumSystemTissuesTransgenic MiceTretinoinWhole OrganismXenobiotic MetabolismXenobioticschemical carcinogenenzyme substrateexpression vectorgene inductioninsightmetabolic abnormality assessmentprogramstoxicant
项目摘要
DESCRIPTION (provided by applicant): CYP2S1 is a recently identified human cytochrome P450, expressed extensively in epithelial tissues. We propose that CYP2S1 plays a significant role in the metabolic activation of environmental procarcinogens, and the metabolism of pharmaceuticals and endogenous compounds. The proposal will address this hypothesis and characterize regulation of the enzyme. There are three specific aims: (i) We have expressed human CYP2S1 in bacteria, and demonstrated that it metabolizes several compounds that are toxic and/or carcinogenic to epithelial tissues. We will also over-express the enzyme in mammalian cells. Using these expression systems, we will screen for additional substrates, and also for procarcinogens that are activated to mutagenic (and therefore probably carcinogenic) derivatives by CYP2S1. The Km and Vmax values will be determined for representative compounds, and the metabolites that are formed will be identified. The degree to which CYP2S1 contributes towards the total metabolism of particular substrates in human epithelial tissues will be determined using an inhibitory antibody to the enzyme, (ii) We have shown that CYP2S1 is inducible by dioxin, carcinogenic polycyclic aromatic hydrocarbons (PAHs), and hypoxia. We will investigate whether the potential Xenobiotic Responsive Elements (XREs), or the potential Antioxidant Response Element (ARE) in the 5' flanking region of the human CYP2S1 gene mediate induction by dioxin and/or PAHs, and address the hypothesis that due to the particular nucleotide sequences of the above XREs, the gene responds better to PAHs than to dioxin in certain cells. We will also analyze the mechanism of hypoxic induction of the gene, (iii) We will generate a knockout mouse for Cyp2s1, and then generate a derivative of this mouse containing the human CYP2S1 gene, including its flanking regulatory regions. This "CYP2S1-humanized" mouse will be used to study the metabolism of substrates of human CYP2S1, the biological consequences of this metabolism, and the regulation of the human CYP2S1 gene by xenobiotics and hypoxia, thus complementing and extending specific aims 1 and 2. Our studies may demonstrate important roles for CYP2S1 in the metabolism of carcinogens, Pharmaceuticals and endogenous compounds, and may ultimately provide opportunities for reducing the deleterious effects of environmental carcinogens and the adverse effects of certain Pharmaceuticals in the human population.
描述(由申请人提供):CYP2S1是最近鉴定的人细胞色素P450,广泛表达于上皮组织中。我们认为CYP2S1在环境致癌物的代谢激活以及药物和内源性化合物的代谢中发挥着重要作用。该提案将解决这一假设并描述酶的调节特征。有三个具体目标:(i)我们在细菌中表达了人类 CYP2S1,并证明它可以代谢几种对上皮组织有毒和/或致癌的化合物。我们还将在哺乳动物细胞中过度表达该酶。使用这些表达系统,我们将筛选其他底物,以及被 CYP2S1 激活为诱变(因此可能致癌)衍生物的原致癌物。将确定代表性化合物的 Km 和 Vmax 值,并鉴定形成的代谢物。 CYP2S1 对人类上皮组织中特定底物总代谢的贡献程度将使用该酶的抑制性抗体来确定,(ii) 我们已经证明 CYP2S1 可以被二恶英、致癌多环芳烃 (PAH) 诱导,并且缺氧。我们将研究人类 CYP2S1 基因 5' 侧翼区域中潜在的异生素反应元件 (XRE) 或潜在的抗氧化反应元件 (ARE) 是否介导二恶英和/或多环芳烃的诱导,并提出以下假设:根据上述 XRE 的特定核苷酸序列,该基因在某些细胞中对 PAH 的反应比对二恶英的反应更好。我们还将分析该基因的缺氧诱导机制,(iii)我们将生成 Cyp2s1 敲除小鼠,然后生成该小鼠的衍生品,该小鼠含有人类 CYP2S1 基因,包括其侧翼调节区。这种“CYP2S1人源化”小鼠将用于研究人类CYP2S1底物的代谢、这种代谢的生物学后果,以及异生素和缺氧对人类CYP2S1基因的调节,从而补充和扩展特定目标1和2。我们的研究可能证明 CYP2S1 在致癌物、药物和内源性化合物代谢中的重要作用,并可能最终为减少环境的有害影响提供机会。致癌物以及某些药物对人群的不利影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OLIVER nmn HANKINSON其他文献
OLIVER nmn HANKINSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OLIVER nmn HANKINSON', 18)}}的其他基金
A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
CRISPR-Cas9 筛选 AHR 诱导 CYP1A1 所需的新型蛋白质
- 批准号:
9276681 - 财政年份:2016
- 资助金额:
$ 24.44万 - 项目类别:
A CRISPR-Cas9 screen for novel proteins required for induction of CYP1A1 by AHR
CRISPR-Cas9 筛选 AHR 诱导 CYP1A1 所需的新型蛋白质
- 批准号:
9112338 - 财政年份:2016
- 资助金额:
$ 24.44万 - 项目类别:
Function and Regulation of Human Cytochrome P4502S1
人细胞色素P4502S1的功能和调控
- 批准号:
7811735 - 财政年份:2009
- 资助金额:
$ 24.44万 - 项目类别:
相似海外基金
The role of transcription factor MEOX2 in lipofibroblast function during alveolarization
转录因子 MEOX2 在肺泡化过程中脂肪成纤维细胞功能中的作用
- 批准号:
10385997 - 财政年份:2022
- 资助金额:
$ 24.44万 - 项目类别:
Characterization of TRPC6 to predict and prevent chemotherapy-related heart failure
TRPC6 的表征可预测和预防化疗相关心力衰竭
- 批准号:
10705329 - 财政年份:2022
- 资助金额:
$ 24.44万 - 项目类别:
Humanized MAPT knockin mouse models for frontotemporal dementia
额颞叶痴呆人源化 MAPT 敲入小鼠模型
- 批准号:
10303887 - 财政年份:2021
- 资助金额:
$ 24.44万 - 项目类别: